Chee Conley Insider Trades

Insider Trading History

Track insider trading activity for Chee Conley. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $0 0 shares
Last Trade
Nov 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$27k 134,797 shares
$0.20
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $27.9 139,504 shares
Last Trade
Oct 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.8k 17,000 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $0 0 shares
Last Trade
Oct 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.8k 17,000 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $26.2 130,797 shares
Last Trade
Oct 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.9k 8,707 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $24.5 122,504 shares
Last Trade
Sep 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$85.5k 50,000 shares
$1.71
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $14.5 72,504 shares
Last Trade
Sep 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$75.5k 50,000 shares
$1.51
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $4.5 22,504 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.9k 3,500 shares
$5.12
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $17.2 86,000 shares
Last Trade
Dec 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229k 86,000 shares
$2.66
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $2.47 12,338 shares
Last Trade
Nov 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 6,004 shares
$2.22
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $3.4 17,000 shares
Last Trade
Oct 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 17,000 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $3.67 18,342 shares
Last Trade
Oct 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 17,000 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $0.268 1,342 shares
Last Trade
Apr 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.7k 658 shares
$2.58
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $1.2 6,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $0.4 2,000 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $7 35,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 35,000 shares
$4.02
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $8.9 44,500 shares
Last Trade
Oct 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 157,000 shares
$6.73
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $20 100,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 180,000 shares
$1.59
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Commercial Officer
Holding Value $72 360,000 shares
Last Trade
Sep 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 360,000 shares
$4.81
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up